Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 07, 2019
Cambrex has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately $2.4 billion, including Cambrex’s net debt.
read more
Samsung BioLogics and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive supranuclear palsy.
read more
The FDA and the EMA are publishing the discussion and main conclusions from a workshop held on November 26, 2018, at the EMA headquarters in London.
read more
Olon S.p.A. announced the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
read more
Starting in July, the commercial brand for Eurofins Alphora will be Eurofins CDMO, falling under the CDMO umbrella in conjunction with Eurofins Amatsigroup.
read more
Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third ADC produced at the site.
read more
Amgen announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus.
read more
As drug manufacturing has globalized, ensuring that companies meet the FDA strict standards for producing safe, effective and high-quality medicines has become increasingly challenging.
read more
Lonza has selected Rockwell Automation for the turnkey implementation of the Lonza strategic vision of bringing the digital factory to nine former Capsugel facilities that manufacture drug capsules.
read more
Genomma Lab has announced the Mexican Federal COFEPRIS has granted the Sanitary License which permits the Company's new manufacturing facility to begin operations.
read more
Catalent held a ground breaking ceremony at its Bloomington, Indiana site to mark the start of construction on a $112 million drug product manufacturing facility.
read more
FUJIFILM Irvine Scientific announced plans to open a third manufacturing facility located in Tilburg, Netherlands.
read more
Teva announced the company has completed the purchase of three buildings on Brandywine Parkway in West Chester, Pa.
read more
Passage Bio has entered into a collaboration agreement with Paragon Gene Therapy for the development of a dedicated manufacturing suite at their facility near Baltimore.
read more
Nexus Pharmaceuticals announced an agreement with the village of Pleasant Prairie, Wisconsin to build a sterile injectable manufacturing facility.
read more